Rothschild & CO Asset Management Us Inc. Biogen Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $8.19 Million - $9.45 Million	-30,925 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $12.3 Million - $16.3 Million	-47,639 Reduced 60.64%	30,925 $8.27 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $9.15 Million - $11.6 Million	-34,019 Reduced 30.22%	78,564 $24.9 Million
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $9.52 Million - $13.2 Million	-43,249 Reduced 27.75%	112,583 $33.4 Million
Q3 2019 Nov 08, 2019	BUY	$217.44 - $243.88 $2.18 Million - $2.45 Million	10,041 Added 6.89%	155,832 $36.3 Million
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $2.38 Million - $2.63 Million	-10,876 Reduced 6.94%	145,791 $34.1 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $400,480 - $626,398	-1,848 Reduced 1.17%	156,667 $37 Million
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $235,889 - $298,779	-847 Reduced 0.53%	158,515 $47.7 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $1.02 Million - $1.33 Million	3,478 Added 2.23%	159,362 $56.3 Million
Q2 2018 Aug 07, 2018	BUY	$257.52 - $306.91 $93,479 - $111,408	363 Added 0.23%	155,884 $45.2 Million
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $9.11 Million - $12.9 Million	35,039 Added 29.08%	155,521 $42.6 Million
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $7.09 Million - $7.94 Million	-23,057 Reduced 16.06%	120,482 $38.4 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $40.4 Million - $47.3 Million	143,539	143,539 $44.9 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.